Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY-Reference-Cited by-同舟云学术

Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY

Published:2007-11-09 Issue:6 Volume:21 Page:459-465
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Recio-Mayoral A.,Kaski J.-C.,McMurray J. J. V.,Horowitz J.,van Veldhuisen D. J.,Remme W. J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-007-6069-4.pdf

Reference15 articles.

1. Yu CM, Abraham WT, Bax J, et al. Predictors of response to cardiac resynchronization therapy (PROSPECT)—study design. Am Heart J. 2005;149:600–5.

2. Gheorghiade M, Gattis WA, O’ Connor CM, et al. Effects of tolvaptan, a vasopressin antagoist, in patients hospitalised with worsening heart failure: a randomised controlled trial. JAMA. 2004;291:1963–71.

3. Udelson JE, McGrew FA, Flores E, et al. Multicenter, randomised, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. J Am Coll Cardiol. 2007;49:2151–9.

4. Gheorghiade M, Orlandi C, Burnett JC, et al. Rationale and design of the multicenter, randomised, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST). J Card Fail. 2005;11:260–9.

5. Konstam MA, Burnett JC, Gheorghiade M, et al. Effects of oral tolvaptan in patients hospitalised for worsening heart failure: the EVEREST outcome trial. JAMA. 2007;297:1319–31.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiology-In-Depth Look: Advances in Antiplatelet Therapy;Pharmaceutical Sciences Encyclopedia;2011-12-16

2. Direct renin inhibition: update on clinical investigations with aliskiren;European Journal of Cardiovascular Prevention & Rehabilitation;2011-02-21

3. The Role of Translational Medicine and Predictive Biomarkers in the Development of Novel, Innovative Treatments for the Management of Chronic Heart Failure: A Pharmaceutical Industry Perspective;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15

4. Section 7: Heart Failure in Patients With Reduced Ejection Fraction;Journal of Cardiac Failure;2010-06

5. Oxidative stress: a key contributor to diabetic cardiomyopathyThis review is one of a selection of papers published in a Special Issue on Oxidative Stress in Health and Disease.;Canadian Journal of Physiology and Pharmacology;2010-03